4.6 Article

Different Periods of Periconceptional Undernutrition Have Different Effects on Growth, Metabolic and Endocrine Status in Fetal Sheep

Journal

PEDIATRIC RESEARCH
Volume 66, Issue 6, Pages 605-613

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1203/PDR.0b013e3181bbde72

Keywords

-

Categories

Funding

  1. Health Research Council of New Zealand
  2. National Research Centre for Growth and Development
  3. Auckland Medical Research Foundation
  4. New Zealand Lottery Board

Ask authors/readers for more resources

Periconceptional undernutrition alters fetal growth and development. However, there are no data on separate effects of undernutrition before and after conception and few on underlying mechanisms. We determined the effects of mild periconceptional undernutrition on late gestation fetal growth, glucose-insulin axis, and maternal and fetal hypothalamic-pituitary-adrenal axes. Ewes were undernourished for 60 d before conception, 30 d after, or both, compared with well-nourished controls. Undernutrition before conception resulted in smaller, slower-growing fetuses with relatively larger placentae. Ewes that gained weight before, but lost weight after mating, or vice versa, had the smallest fetuses. Fetuses of ewes undernourished only before conception grew more slowly following instrumentation, and fetuses in both preconception undernutrition groups slowed their growth with a maternal fast. The fetal glucose-insulin axes and maternal and fetal hypothalamic-pituitary-adrenal axis were not different among groups. Maternal undernutrition at different periods around conception has different effects on fetal growth trajectory that are not reflected in size in late gestation. Preconceptional undernutrition alone alters fetal growth responses to late gestation stressors, suggesting that maternal nutrition is important at both times, and that fetal effects are neither due solely to substrate limitation, nor to excess fetal glucocorticoid exposure at the time of undernutrition. (Pediatr Res 66: 605-613, 2009)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pediatrics

Odor-active volatile compounds in preterm breastmilk

Mariana Muelbert, Laura Galante, Tanith Alexander, Jane E. Harding, Chris Pook, Frank H. Bloomfield

Summary: This study found that sensory-active volatile fatty acids are major contributors to the smell of preterm breastmilk and are influenced by the lactation stage and maternal characteristics. The concentration of medium-chain fatty acids was higher in colostrum compared to transitional breastmilk, and this concentration was associated with socioeconomic status, gestational diabetes, and ethnicity. Longitudinal analysis showed that fatty acids increased with advancing lactation.

PEDIATRIC RESEARCH (2022)

Article Pediatrics

Effect of prophylactic dextrose gel on the neonatal gut microbiome

Sophie L. St Clair, Jane E. Harding, Justin M. O'Sullivan, Gregory D. Gamble, Jane M. Alsweiler, Tommi Vatanen, H. P. O. D. Study Group

Summary: This study aimed to investigate the effect of dextrose gel on the neonatal gut microbiome, showing no impact on the microbiome. Mode of birth, type of milk fed, hospital of birth, and ethnicity were associated with differences in the neonatal microbiome.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2022)

Article Pediatrics

Variations in New Zealand and Australian guidelines for the management of neonatal hypoglycaemia: A secondary analysis from the hypoglycaemia Prevention with Oral Dextrose gel Trial (hPOD)

Aakash B. Rajay, Jane E. Harding

Summary: There is wide variation in guideline recommendations for the management of neonatal hypoglycaemia across New Zealand and Australian neonatal units, including differences in diagnostic thresholds, monitoring methods, and treatment protocols.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2022)

Article Multidisciplinary Sciences

Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: A secondary analysis of the ASTEROID Trial

Olivia J. Hofer, Jane E. Harding, Thach Tran, Caroline A. Crowther

Summary: This study aimed to determine whether there were differences in maternal, infant, and childhood health outcomes between the use of dexamethasone or betamethasone as a repeat antenatal corticosteroid for women at risk of preterm birth after an initial course. The results showed that there were no significant differences in health outcomes between the two groups.

PLOS ONE (2022)

Review Nutrition & Dietetics

Sex-Specific Effects of Nutritional Supplements for Infants Born Early or Small: An Individual Participant Data Meta-Analysis (ESSENCE IPD-MA) II: Growth

Luling Lin, Greg D. Gamble, Caroline A. Crowther, Frank H. Bloomfield, Massimo Agosti, Stephanie A. Atkinson, Augusto Biasini, Nicholas D. Embleton, Fernando Lamy Filho, Christoph Fusch, Maria L. Gianni, Hayriye Goezde Kanmaz Kutman, Winston Koo, Ita Litmanovitz, Colin Morgan, Kanya Mukhopadhyay, Erica Neri, Jean-Charles Picaud, Niels Rochow, Paola Roggero, Kenneth Stroemmen, Maw J. Tan, Francesco M. Tandoi, Claire L. Wood, Gitte Zachariassen, Jane E. Harding

Summary: Neonatal nutritional supplements may improve early growth for infants born small, but the effects on long-term growth are uncertain and may vary by sex. These supplements can increase length and bone mineral content in infancy, but do not affect BMI in childhood. Supplementation can enhance height z-score in male toddlers, but not in females.

NUTRIENTS (2022)

Article Pediatrics

Outcome at 4.5 years after dextrose gel treatment of hypoglycaemia: follow-up of the Sugar Babies randomised trial

Deborah L. Harris, Greg D. Gamble, Jane E. Harding

Summary: Treatment of neonatal hypoglycaemia with dextrose gel does not increase the rate of neurosensory impairment, but further assessment of visual processing and growth may be warranted.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2023)

Article Obstetrics & Gynecology

Postpartum anaemia in three New Zealand district health board regions: An observational study of incidence and management

Esther Calje, Joy Marriott, Charlotte Oyston, Lesley Dixon, Frank Bloomfield, Katie Groom

Summary: This study reports the incidence of postpartum anaemia in three district health board regions in New Zealand and describes the current management of moderate to severe postpartum anaemia, including differences among different ethnicities.

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2023)

Article Clinical Neurology

Cross-cultural validity and reliability of the BRIEF-P at age 2 and 4.5 years in children born at risk of neonatal hypoglycemia

Ryan Jim San Diego, Nike Franke, Jane Elizabeth Harding, Trecia Ann Wouldes

Summary: Executive function is an important neurocognitive process for self-regulation of behavior and acquisition of social and cognitive competencies. While there are valid measures for adult and adolescent executive function, there is a lack of valid measures for preschool children. This study evaluated the cross-cultural validity and reliability of the Behavior Rating Inventory of Executive Function Preschool Version (BRIEF-P) in New Zealand Maori and European parents of children with neonatal hypoglycemia. The results showed that the BRIEF-P is a highly reliable and valid instrument.

CHILD NEUROPSYCHOLOGY (2023)

Article Pediatrics

Betamethasone for Preterm Birth: Auckland Steroid Trial Full Results and New Insights 50 Years on

Anthony G. B. Walters, Luling Lin, Caroline A. Crowther, Greg D. Gamble, Stuart R. Dalziel, Jane E. Harding

Summary: The objective of this study was to present the complete results of the first randomized trial of antenatal corticosteroids conducted 50 years ago using modern analysis and reporting methods. The results showed that antenatal betamethasone administered to women at risk of preterm birth between 24 and less than 37 weeks of gestation significantly reduces the incidence of respiratory distress syndrome, with greater efficacy in male infants than female infants. Doubling the dose of betamethasone does not provide additional benefit.

JOURNAL OF PEDIATRICS (2023)

Article Pediatrics

Mid-Childhood Outcomes after Dextrose Gel Treatment of Neonatal Hypoglycaemia: Follow-Up of the Sugar Babies Randomized Trial

Sophie L. St Clair, Darren W. T. Dai, Deborah L. Harris, Gregory D. Gamble, Christopher J. D. McKinlay, Samson Nivins, Rajesh K. Shah, Benjamin Thompson, Jane E. Harding

Summary: In the treatment of neonatal hypoglycaemia, dextrose gel is safe and effective, but at 9-10 years old, children in the dextrose gel group had slightly lower visual perception abilities compared to the placebo group.

NEONATOLOGY (2023)

Review Medicine, Research & Experimental

From fetus to neonate: A review of cardiovascular modeling in early life

Robyn W. May, Gonzalo Maso D. Talou, Alys R. Clark, Jonathan P. Mynard, Joseph J. Smolich, Pablo J. Blanco, Lucas O. Mueller, Thomas L. Gentles, Frank H. Bloomfield, Soroush Safaei

Summary: Computational modeling is widely used in the study of cardiovascular hemodynamics for medical research and improving the diagnosis and treatment of cardiovascular diseases. Most existing cardiovascular models focus on the adult circulatory system, but the perinatal period is unique as cardiovascular physiology undergoes significant changes. This review discusses computational models of the cardiovascular system in early life, their applications, and proposes a roadmap for developing an open-source model spanning fetal, perinatal, and postnatal periods.

WIRES MECHANISMS OF DISEASE (2023)

Review Nutrition & Dietetics

Nutrition guidelines for preterm infants: A systematic review

Meiliana Meiliana, Tanith Alexander, Frank H. Bloomfield, Barbara E. Cormack, Jane E. Harding, Orla Walsh, Luling Lin

Summary: There is currently a lack of high-quality and consistent nutrition guidelines for preterm infants, which leads to substantial variation in practice.

JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2023)

Article Ophthalmology

Associations between neonatal nutrition and visual outcomes in 7-year-old children born very preterm

Mukhit Kulmaganbetov, Myra Leung, Jane M. Alsweiler, Joanna Black, Frank H. Bloomfield, Greg D. Gamble, Jane E. Harding, Yannan Jiang, Tanya Poppe, Anna C. Tottman, Trecia A. Wouldes, Benjamin Thompson

Summary: This study aimed to assess the effect of increased protein intake on ophthalmic and visual development in school-age children born very preterm. The results showed that there were subtle and complex associations between early neonatal nutrition and visual development at school age.

OPHTHALMIC AND PHYSIOLOGICAL OPTICS (2023)

Article Pediatrics

Perspectives of adult offspring of participants recruited to a randomised trial in pregnancy: a qualitative study

Nike Franke, Trecia Ann Wouldes, Gavin Thomas Lumsden Brown, Kim Ward, Jenny Rogers, Jane E. Harding

Summary: This study explores the views of young adults on their participation in medical research during childhood, specifically focusing on the acceptability of consent and their priorities regarding health, development, and well-being as potential trial outcomes. The findings indicate that participants were comfortable with their parents giving consent on their behalf, but highlighted the challenges of obtaining autonomous child assent. They generally expressed satisfaction with the outcomes investigated in the follow-up studies, while also suggesting additional outcomes of interest such as mental health and learning disabilities.

ARCHIVES OF DISEASE IN CHILDHOOD (2023)

Review Pediatrics

Glucagon for Neonatal Hypoglycaemia: Systematic Review and Meta-Analysis

Eamon P. G. Walsh, Jane M. Alsweiler, Julena Ardern, Sara M. Hanning, Jane E. Harding, Christopher J. D. McKinlay

Summary: There is insufficient evidence to support the efficacy and safety of glucagon for the treatment of neonatal hypoglycemia. Current evidence suggests that glucagon may increase blood glucose levels, but recurrent hypoglycemia is common. High-quality randomized controlled trials are needed to determine the role of glucagon in managing neonatal hypoglycemia.

NEONATOLOGY (2022)

No Data Available